Allstate Corporation’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.36M Buy
26,128
+12,002
+85% +$1.1M 0.03% 453
2025
Q4
$1.27M Buy
14,126
+7,052
+100% +$669K 0.02% 473
2025
Q3
$697K Buy
+7,074
New +$701K 0.02% 452
2025
Q2
Sell
-7,537
Closed -$853K 576
2025
Q1
$853K Buy
7,537
+1,208
+19% +$129K 0.03% 380
2024
Q4
$669K Buy
+6,329
New +$679K 0.02% 403
2023
Q1
Sell
-9,663
Closed -$1.23M 565
2022
Q4
$1.23M Hold
9,663
0.04% 303
2022
Q3
$1.01M Sell
9,663
-1,148
-11% -$126K 0.03% 334
2022
Q2
$1.14M Sell
10,811
-736
-6% -$87.3K 0.04% 309
2022
Q1
$1.48M Buy
11,547
+5,048
+78% +$608K 0.04% 316
2021
Q4
$802K Buy
6,499
+516
+9% +$67.5K 0.02% 578
2021
Q3
$850K Sell
5,983
-697
-10% -$103K 0.04% 332
2021
Q2
$1.04M Sell
6,680
-619
-8% -$100K 0.04% 294
2021
Q1
$1.13M Buy
7,299
+785
+12% +$122K 0.04% 287
2020
Q4
$974K Sell
6,514
-673
-9% -$95.1K 0.03% 292
2020
Q3
$950K Sell
7,187
-399
-5% -$52.1K 0.03% 260
2020
Q2
$879K Buy
7,586
+1,086
+17% +$125K 0.03% 283
2020
Q1
$638K Sell
6,500
-8,220
-56% -$1.08M 0.03% 304
2019
Q4
$2.14M Buy
14,720
+61
+0.4% +$8.42K 0.04% 283
2019
Q3
$1.95M Sell
14,659
-211
-1% -$27.3K 0.03% 291
2019
Q2
$1.7M Buy
14,870
+1,852
+14% +$217K 0.03% 304
2019
Q1
$1.61M Sell
13,018
-1,740
-12% -$198K 0.04% 256
2018
Q4
$1.49M Buy
+14,758
New +$1.66M 0.05% 246

Other funds holding ZBH

Allstate Corporation's ZBH Position: Q1 2026 in Review

Allstate Corporation increased its Zimmer Biomet (ZBH) stake by 85% in Q1 2026, buying an estimated $1.1M and bringing the position to 26,128 shares worth $2.36M. The position accounts for 0.03% of the portfolio, ranked #453.

Allstate Corporation first reported a position in ZBH in Q4 2018 and has held it in 22 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Allstate Corporation held 26,128 shares of Zimmer Biomet worth $2.36M as of Q1 2026.
  • Allstate Corporation bought 12,002 Zimmer Biomet shares in Q1 2026, an estimated $1.1M.
  • Zimmer Biomet made up 0.03% of Allstate Corporation's portfolio in Q1 2026, its #453 holding.
  • Allstate Corporation first reported a position in Zimmer Biomet in Q4 2018 and has held it in 22 quarters since.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.